Objectives: The study objective was to determine the predictors of new-onset arrhythmia among infants with single-ventricle anomalies during the postNorwood hospitalization and the association of those arrhythmias with postoperative outcomes (ventilator time and length of stay) and interstage mortality. Methods: After excluding patients with preoperative arrhythmias, we used data from the Pediatric Heart Network Single Ventricle Reconstruction Trial to identify risk factors for tachyarrhythmias (atrial fibrillation, atrial flutter, supraventricular tachycardia, junctional ectopic tachycardia, and ventricular tachycardia) and atrioventricular block (second or third degree) among 544 eligible patients. We then determined the association of arrhythmia with outcomes during the post-Norwood hospitalization and interstage period, adjusting for identified risk factors and previously published factors. Results: Tachyarrhythmias were noted in 20% of subjects, and atrioventricular block was noted in 4% of subjects. Potentially significant risk factors for tachyarrhythmia included the presence of modified Blalock-Taussig shunt (P ¼ .08) and age at Norwood (P ¼ .07, with risk decreasing each day at age 8-20 days); the only significant risk factor for atrioventricular block was undergoing a concomitant procedure at the time of the Norwood (P ¼ .001), with the greatest risk being in those undergoing a tricuspid valve procedure. Both tachyarrhythmias and atrioventricular block were associated with longer ventilation time and length of stay (P<.001 for all analyses). Tachyarrhythmias were not associated with interstage mortality; atrioventricular block was associated with mortality among those without a pacemaker in the unadjusted analysis (hazard ratio, 2.3; P ¼ .02), but not after adding covariates. Conclusions: Tachyarrhythmias are common after the Norwood procedure, but atrioventricular block may portend a greater risk for interstage mortality. (J Thorac Cardiovasc Surg 2017;153:638-45) Atrioventricular block, but not tachyarrhythmia, is associated with increased mortality after the Norwood procedure.
Over the past 40 years, survival for the Norwood procedure and staged reconstruction for infants with hypoplastic left heart syndrome and related single right ventricle anomalies have dramatically improved. [1] [2] [3] What was once a universally fatal disease in infancy is now a disease in which transplant-free survival to 1 year of age is 68%. 4 However, with this improved survival comes an increased recognition of and focus on morbidity. One important aspect of morbidity in this population is the prevalence of arrhythmias.
Although arrhythmias have been well studied in patients with single ventricle congenital heart disease who have survived the Fontan procedure, 5-10 the prevalence and impact of arrhythmias after the Norwood procedure are not well known. Most prior studies of arrhythmias in infants with congenital heart disease have included a variety of operations, [11] [12] [13] [14] thus limiting the knowledge that is specific to those with single ventricle physiology after the Norwood procedure. One prior study from the Pediatric Heart Network Single Ventricle Reconstruction (SVR) Trial did examine some outcomes in those with arrhythmias: A total of 13 of 544 patients were noted to have perioperative second-or third-degree atrioventricular block in the intensive care unit on the day of the Norwood procedure, with heart block being associated with the development of renal failure, hepatic failure, and mediastinitis. 15 This study did not examine the risk factors for the development of atrioventricular block or the interstage outcomes for those with atrioventricular block, and it did not examine any aspects of tachyarrhythmias.
With this limited knowledge regarding the development and impact of tachyarrhythmias and atrioventricular block in infants with single ventricle physiology, we examined data from the SVR Trial in an effort to (1) determine the predictors of new-onset arrhythmia during the postoperative period after the Norwood procedure and (2) compare the short-and intermediateterm outcomes of those with postoperative arrhythmia versus those without arrhythmia. We hypothesized that there would be important preoperative and perioperative predictors of postoperative arrhythmias and that postoperative arrhythmias would be associated with poorer outcomes in these fragile infants.
MATERIALS AND METHODS Study Design and Data Collection
We performed a retrospective cohort study using data from the Pediatric Heart Network SVR Trial, the methods of which have been described. 16 Briefly, infants with a functionally single ventricle lesion with a single morphologic right ventricle were randomized to undergo a Norwood operation with a modified Blalock-Taussig shunt (MBTS) or a right ventricle-to-pulmonary artery shunt (RVPAS) at 15 clinical centers in North America, with institutional review board approval obtained at each participating center. 17 Data were collected on a variety of demographic, preoperative, operative, and postoperative factors, including the occurrence of arrhythmias, as well as on a variety of outcomes in the period after the Norwood operation until the stage II operation or 12 months of age, whichever occurred first. In the SVR Trial, only arrhythmias that required medication or other treatment during the post-Norwood hospitalization were captured, with the date of onset being recorded. Tachyarrhythmias included atrial fibrillation, atrial flutter, supraventricular tachycardia, junctional ectopic tachycardia, and ventricular tachycardia. Atrioventricular block included second-or third-degree block, but the information on which type of block was not recorded; episodes of first-degree block were not captured. In regard to therapy, information on pacemakers was collected at the time of pacemaker implantation, but data on medication use were collected only at the time of discharge from the Norwood hospitalization.
All subjects enrolled in the SVR Trial were eligible for this study. We performed separate analyses for tachyarrhythmia and atrioventricular block. We excluded those who died during the Norwood procedure from all analyses. For the specific tachyarrhythmia and atrioventricular block analyses, we further excluded patients with those respective arrhythmias before the Norwood procedure (ie, patients with preoperative tachyarrhythmia were excluded from the tachyarrhythmia analyses and patients with preoperative atrioventricular block were excluded from the atrioventricular block analyses) (Figure 1 ).
Statistics
After performing summary statistics describing the prevalence of postoperative tachyarrhythmia and atrioventricular block, we performed risk factor analyses to identify predictors of these arrhythmias during the post-Norwood hospitalization. Univariate analyses were performed on more than 80 demographic, preoperative, and operative factors using logistic regression models. Factors that had a P value of less than .20 and were thought to be clinically relevant were then used as candidate predictors in the stepwise model selection process to construct the multivariable models (Appendix 1). In addition, nonlinearly associated continuous variables identified by generalized additive modeling were appropriately transformed before use in stepwise selection. Final Abbreviations and Acronyms CI ¼ confidence interval MBTS ¼ modified Blalock-Taussig shunt RVPAS ¼ right ventricle-to-pulmonary artery shunt SVR ¼ Single Ventricle Reconstruction Scanning this QR code will take you to the appendices and video for this article.
multivariable logistic regression models include all predictors with P values less than .05, and model selection results were confirmed via a separate bootstrap analysis. Because many variables may be dependent on site, a subsequent analysis was performed by adding site to these models.
Next, we examined the association of tachyarrhythmia or atrioventricular block with short-term and intermediate-term outcomes of interest. Short-term outcomes included total duration of ventilation (days) and length of hospital stay (days) after the Norwood procedure, excluding those who died or received a heart transplant during the Norwood hospitalization. For the models examining duration of ventilation, we included only those cases in which the onset of arrhythmia occurred before the date of initial extubation. The ventilation days and hospital length of stay were log transformed (with natural base) to attain an approximately normal distribution. Multivariable linear regression analyses were then performed to inform final adjusted models for the relationship between these 2 short-term outcomes and the occurrence of tachyarrhythmia or atrioventricular block, while controlling for covariates determined from a review of previously published studies or from univariate linear regression of the variables in Appendix 1. The covariates included were gestational age (<37 vs !37 weeks), presence of genetic syndrome, age at time of Norwood procedure, race (white, black, other), gender, shunt type received, anatomic subtype (aortic stenosis/mitral stenosis and related diagnoses), prenatal diagnosis, total support time during the Norwood procedure (total time on cardiopulmonary bypass), ultrafiltration during or after Norwood procedure, use of extracorporeal membrane oxygenation during the Norwood procedure, presence of postoperative moderate/severe tricuspid regurgitation by echocardiography, and center volume ( 15, (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , >30 patients receiving the Norwood procedure per year). For the length of stay analysis for the atrioventricular block cohort, pacemaker implantation also was included as a covariate in the final multivariable model. Pacemaker implantation was not included in the length of ventilation analyses because no patient had pacemaker implantation before the date of initial extubation. Least-squares means are used to report covariate-adjusted number of days.
The intermediate-term outcome of interest was death or transplant before the stage II procedure, including those who died or received a transplant before discharge after the Norwood procedure. The relationship between transplant-free survival since the Norwood procedure and tachyarrhythmia or atrioventricular block was examined using Kaplan-Meier estimation, with censoring at the time of stage II procedure or at 12 months post-Norwood, whichever occurred first. If this relationship was significant, then further analyses with hazard ratios and P values were calculated from Cox proportional-hazards regression models. To be consistent with the prior analyses, the same covariates were used in the adjusted Cox proportional-hazards models. The 5 subjects who had a pacemaker implanted during the post-Norwood hospitalization were excluded from the Kaplan-Meier survival analysis of atrioventricular block because of low numbers, but were listed as a separate group in the adjusted Cox proportional-hazards regression analysis. All analyses were conducted with SAS version 9.3 (SAS Institute, Inc, Cary, NC) and R version 3.0.3 (The R Project for Statistical Computing, Auckland, New Zealand). 
RESULTS
Of the 549 patients eligible for the SVR Trial, 544 underwent the Norwood procedure and were available for analysis. Subjects were predominantly male, white, and non-Hispanic. More than 75% of patients were diagnosed prenatally, and the average gestational age was 38 weeks. The average age at the Norwood procedure was 5 days (Table 1) . Among the 544 included subjects, 114 (21%) experienced at least 1 episode of a postoperative tachyarrhythmia, and 21 (4%) experienced at least 1 episode of postoperative atrioventricular block; 11 subjects had multiple types of arrhythmia ( Figure 2 ).
Tachyarrhythmia
Among the 529 subjects who did not have a preoperative tachyarrhythmia, 108 had at least 1 episode of a postoperative tachyarrhythmia. After identifying 18 potential factors associated with the development of tachyarrhythmia in the univariate analysis, there were 3 key factors that were significant in the multivariable model. Those with a final shunt type of MBTS had 1.55 times the odds of developing tachyarrhythmia compared with those with an RVPAS (95% confidence interval [CI], 1.00-2.42; P ¼ .05), and those who underwent ultrafiltration (n ¼ 459) during or after the Norwood procedure had 3.73 times the odds of tachyarrhythmia compared with those who did not receive ultrafiltration (95% CI, 1.17-9.68; P ¼ .003). Although there was no association between the age at time of Norwood and the development of tachyarrhythmia in the first week of life, from 8 to 20 days, the likelihood of developing tachyarrhythmia decreased gradually but significantly each day 0.76 (95% CI, 0.61-0.96). There were insufficient data beyond 20 days of age. When site was added to the model (Table 2) , there were small changes in the estimates for MBTS, RVPAS, and age at time of Norwood, although the P values for MBTS and RVPAS did exceed .05 at .08 and .07, respectively. Notably, however, with site in the model the P value for ultrafiltration was .97, suggesting that ultrafiltration may have been a surrogate for site.
Tachyarrhythmia was significantly associated with shortterm outcomes during the post-Norwood hospitalization. Compared with those without any postoperative arrhythmia, subjects with a tachyarrhythmia had significantly more days on the ventilator and a longer postoperative length of stay (Table 3) . However, development of postoperative tachyarrhythmia was not statistically associated with transplant-free survival to stage II procedure (Figure 3, A) .
Atrioventricular Block
Among the 542 subjects who did not have atrioventricular block before the Norwood operation, 21 (4%) had atrioventricular block postoperatively. Of the 8 potential factors identified by univariate analysis as being associated with atrioventricular block, only 1 factor remained in the multivariable model after stepwise regression. Patients with ''other procedures done at time of Norwood'' had 4.44 times the odds of developing (Table 2 ). These other procedures included repair of the atrioventricular valve, branch pulmonary arterioplasty, repair of total anomalous pulmonary venous connections, and resection of endofibroelastosis. The odds of developing atrioventricular block were greatest for those undergoing a tricuspid valve procedure (Table 4) . Atrioventricular block was associated with outcomes in both the short and the intermediate term. During the post-Norwood hospitalization, subjects who developed atrioventricular block had significantly more ventilator days and length of stay (Table 3) . Of the 21 subjects who had atrioventricular block in the postoperative period, 5 had a pacemaker placed during that hospitalization. The 16 subjects with atrioventricular block without a pacemaker had significantly decreased transplant-free survival to stage II procedure compared with those without any postoperative arrhythmia (Figure 3, B) . This association also was seen in the unadjusted Cox proportional hazard regression analysis, with those with atrioventricular block without a pacemaker having 2.26 times the hazard of mortality or transplant before stage II procedure compared with those without an arrhythmia (95% CI, 1.10-4.65; P ¼ .03) ( Table 5 ). However, after adding covariates to the model, this finding was no longer significant. Overall, 10 of the 21 subjects with atrioventricular block died or received a transplant and did not survive to the stage II procedure (Appendix 2).
DISCUSSION
In this large, multicenter study, arrhythmias were common after the Norwood procedure and associated with poorer outcomes. More than 20% of subjects had a tachyarrhythmia postoperatively, with the presence of MBTS and younger age being potentially important risk factors. Tachyarrhythmias were associated with longer time to extubation and total length of stay, but they were not associated with lower survival. Postoperative second-or third-degree atrioventricular block was less common, occurring in only 4% of subjects. The only identified risk factor for block was having multiple procedures performed at the time of the Norwood operation, with the greatest risk being in those undergoing a tricuspid valve procedure. Atrioventricular block was significantly associated with increased time to extubation and total length of stay, with a trend toward decreased transplant-free survival to the stage II procedure (Video 1). 
Tachyarrhythmias
The findings regarding the development of tachyarrhythmias after the Norwood procedure differ somewhat from 2 prior studies. First, the rate of postoperative tachyarrhythmias in approximately 20% of subjects is lower than that of recently published single-center studies, which found rates of 50% (among 66 subjects) 18 and 35% (among 98 subjects). 19 These varying rates may be due to differences in study definition (only cases in which treatment was administered met inclusion in our study) or methods of case ascertainment. Second, there are differences with regard to risk factors for the development of tachyarrhythmias. These prior studies did not find age at Norwood to be a risk factor. With regard to shunt type, there are mixed findings. Whereas in this study, MBTS was potentially associated with the development of tachyarrhythmia, Gist and colleagues 19 did not find shunt type to be a significant factor, and McFerson and colleagues 18 found MBTS to have a protective effect. Because our cohort is larger than those of these prior studies, we believe that our study provides the most accurate estimate of risk.
The findings in this study are in agreement with these prior single studies with regard to the relationship between presence of tachyarrhythmias and outcomes. Tachyarrhythmias are associated with significant morbidity during the postoperative period, particularly a longer length of stay. 18 However, the increased morbidity does not translate to an increase in mortality. Our study and the 2 smaller studies previously mentioned 18, 19 found no tachyarrhythmia-associated increase in mortality from the time of the Norwood procedure to the time of the stage II procedure. One small, single-center study of 50 patients previously found an association of arrhythmia with mortality before the stage II procedure, but this study included both tachyarrhythmias and bradyarrhythmias, and was limited only to those who survived the initial hospitalization after the Norwood procedure. 20 It is unclear whether there is no association of tachyarrhythmia with mortality or whether any such association is mitigated with current treatments. This study was not designed to answer such a question, and these results would not suggest any change in the current management of tachyarrhythmias.
Atrioventricular Block
To our knowledge, this study is the first to investigate the risk factors specifically for the development of atrioventricular block after the Norwood procedure, possibly because of the small numbers of cases seen. A separate study from other investigators using a limited public version of the SVR dataset recently found results similar to ours with regard to the outcomes after atrioventricular block, with minor insignificant differences presumably due to arbitrary methodologic decisions. 21 Before the SVR study, 1 single-center study examined the impact of atrioventricular block after surgery for singleventricle congenital heart disease. In the 5 of 86 subjects who developed second-or third-degree atrioventricular block after the Norwood operation, Trivedi and colleagues 22 found a significant association of atrioventricular block with mortality, with none of the 5 subjects surviving to the stage II procedure. In our study, atrioventricular block was associated with decreased transplant-free survival in the Kaplan-Meier analysis and the unadjusted Cox proportional-hazards regression analysis, but this finding did not meet significance (P ¼ .098) in the adjusted Cox proportional-hazards regression analysis. This failure to achieve significance may have been due to attempting to include 13 covariates in a model with only 16 subjects with atrioventricular block. Nevertheless, the finding that atrioventricular block may be associated with decreased transplant-free survival is an important one. Previously, it has been shown that 24% of the deaths in the SVR Trial were due to unexplained causes. 23 Given the results of our study, one must consider whether untreated or recurrent atrioventricular block may have been a contributing factor in such cases. Compared with patients without any arrhythmia, those with a history of atrioventricular block, but without a pacemaker, had greater than 2 times the hazards of mortality or transplant before the stage II procedure. Of the 9 subjects with atrioventricular block who were discharged to home without a pacemaker, 3 died before the stage II procedure. This risk of increased mortality has similarly been seen in patients with tetralogy of Fallot who had transient complete heart block. 24 Current guidelines would certainly support ''postoperative advanced second or third-degree atrioventricular block that is not expected to resolve or that persists at least 7 days after cardiac surgery'' as a class I indication for pacemaker implantation. 25 However, guidelines also state that pacemaker implantation is not indicated for ''postoperative atrioventricular block with return of normal atrioventricular conduction in the otherwise asymptomatic patient.'' Presumably, unless they were being externally paced in anticipation of a transplant, the 16 subjects in our study who did not receive a pacemaker had a return to normal conduction yet were still at increased risk for mortality or transplant before stage II procedure. With only 5 subjects in our study with atrioventricular block who received a pacemaker (2 of whom were discharged to home after the Norwood and subsequently survived to the stage II procedure), our study is underpowered to determine whether pacemaker implantation can decrease mortality, but the consideration of such an intervention would not be unreasonable.
Study Limitations
This study is not without its limitations. First, only episodes of arrhythmia that were managed with medication or other treatment were included. Because this threshold may vary by center or physician, we may be under-or overdetecting arrhythmia incidence. The mode and timing of treatment may vary by center or physician, thus limiting our ability to make strong conclusions regarding therapies. Second, information regarding the duration or specific treatment of arrhythmias was not recorded. This limits our ability to draw inferences about how certain management options may affect the outcomes. Third, limited clinical detail about atrioventricular block exists in the database, including the degree and duration of block, need for temporary pacing, and timing of resumption of sinus rhythm. There may be important differences in outcomes for second-versus third-degree atrioventricular block that we are unable to discern. Fourth, the rarity of certain events, such as atrioventricular block, may have limited the power to detect important differences in outcomes. Finally, although we found that atrioventricular block may be associated with increased mortality even after controlling for degree of atrioventricular valve insufficiency, we also found that having concomitant procedures such as atrioventricular valve repair may be associated with the development of atrioventricular block. Our study was not powered to distinguish whether mortality associated with atrioventricular block actually may indicate mortality associated with atrioventricular valve repair.
CONCLUSIONS
Arrhythmias, particularly tachyarrhythmias, are common after the Norwood procedure. MBTS and younger age are potentially associated with the development of tachyarrhythmias, whereas undergoing concomitant procedures with the Norwood are associated with atrioventricular block, particularly procedures including the tricuspid valve. Both types of arrhythmias are associated with greater short-term morbidity, but only atrioventricular block may be associated with increased intermediate-term mortality. Optimal strategies to improve the outcomes for those with atrioventricular block, such as the use of an implantable pacemaker, remain unclear. 
